Zhejiang Tiantie Science and Technology Co., Ltd. (SHE:300587)
6.19
-0.11 (-1.75%)
At close: Jan 30, 2026
SHE:300587 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 884.09 | 1,429 | 1,168 | 1,536 | 1,642 | 1,199 |
Other Revenue | 706.35 | 706.35 | 338.94 | 184.16 | 70.88 | 36.56 |
| 1,590 | 2,136 | 1,507 | 1,720 | 1,713 | 1,235 | |
Revenue Growth (YoY) | -22.45% | 41.69% | -12.39% | 0.42% | 38.69% | 24.75% |
Cost of Revenue | 1,160 | 1,656 | 1,588 | 729.81 | 840.4 | 638.91 |
Gross Profit | 430.38 | 479.62 | -80.66 | 990.61 | 872.87 | 596.4 |
Selling, General & Admin | 411.03 | 343.05 | 345.16 | 270.91 | 264.48 | 214.44 |
Research & Development | 101.85 | 75.45 | 76.43 | 68.65 | 74.82 | 42.16 |
Other Operating Expenses | 21.17 | 12.17 | 5.91 | 8.94 | 9.28 | 5.74 |
Operating Expenses | 495.72 | 451.23 | 500.43 | 437.81 | 419.92 | 292.27 |
Operating Income | -65.35 | 28.39 | -581.09 | 552.8 | 452.95 | 304.13 |
Interest Expense | -76.55 | -71.73 | -59.59 | -45.43 | -38.65 | -42.19 |
Interest & Investment Income | 15.08 | 53.47 | 7.32 | 5.95 | 3.46 | 5.52 |
Currency Exchange Gain (Loss) | -0.42 | -0.42 | -2.26 | 0.39 | -0.19 | 0.25 |
Other Non Operating Income (Expenses) | -3.7 | -3.5 | -1.15 | 0.68 | -9.68 | -7.36 |
EBT Excluding Unusual Items | -130.94 | 6.21 | -636.78 | 514.39 | 407.89 | 260.35 |
Impairment of Goodwill | - | - | -36.9 | - | -8.65 | - |
Gain (Loss) on Sale of Investments | 4.01 | -7.42 | -30.16 | -16.99 | -11.44 | - |
Gain (Loss) on Sale of Assets | 0.27 | 0.12 | -11.26 | 0.32 | 1.09 | -0.01 |
Asset Writedown | 5.64 | - | -1.06 | -0 | -0.13 | -0.06 |
Legal Settlements | - | - | - | -27.33 | - | - |
Other Unusual Items | 8.68 | 3.93 | -17.4 | 4.86 | 3.66 | -6.82 |
Pretax Income | -112.35 | 2.85 | -733.56 | 475.25 | 392.42 | 253.47 |
Income Tax Expense | -54.21 | -8.71 | -60.38 | 75.56 | 73.6 | 41.64 |
Earnings From Continuing Operations | -58.14 | 11.56 | -673.18 | 399.69 | 318.83 | 211.83 |
Minority Interest in Earnings | -8.81 | 3.65 | 19.57 | 10.38 | -16.42 | -15.73 |
Net Income | -66.95 | 15.2 | -653.61 | 410.08 | 302.41 | 196.1 |
Net Income to Common | -66.95 | 15.2 | -653.61 | 410.08 | 302.41 | 196.1 |
Net Income Growth | - | - | - | 35.60% | 54.21% | 54.71% |
Shares Outstanding (Basic) | 1,484 | 1,520 | 1,089 | 1,079 | 976 | 921 |
Shares Outstanding (Diluted) | 1,484 | 1,520 | 1,089 | 1,079 | 976 | 921 |
Shares Change (YoY) | 25.75% | 39.57% | 0.95% | 10.62% | 5.96% | 4.09% |
EPS (Basic) | -0.05 | 0.01 | -0.60 | 0.38 | 0.31 | 0.21 |
EPS (Diluted) | -0.05 | 0.01 | -0.60 | 0.38 | 0.31 | 0.21 |
EPS Growth | - | - | - | 22.58% | 45.54% | 48.64% |
Free Cash Flow | -522.64 | -636.54 | -1,275 | -503 | -60.47 | -87.84 |
Free Cash Flow Per Share | -0.35 | -0.42 | -1.17 | -0.47 | -0.06 | -0.10 |
Dividend Per Share | 0.030 | 0.030 | - | 0.030 | 0.047 | 0.045 |
Dividend Growth | - | - | - | -35.76% | 3.78% | 46.10% |
Gross Margin | 27.06% | 22.46% | -5.35% | 57.58% | 50.95% | 48.28% |
Operating Margin | -4.11% | 1.33% | -38.55% | 32.13% | 26.44% | 24.62% |
Profit Margin | -4.21% | 0.71% | -43.36% | 23.84% | 17.65% | 15.87% |
Free Cash Flow Margin | -32.86% | -29.80% | -84.58% | -29.24% | -3.53% | -7.11% |
EBITDA | 4.15 | 100.12 | -506.38 | 623.48 | 509.16 | 355.33 |
EBITDA Margin | 0.26% | 4.69% | -33.60% | 36.24% | 29.72% | 28.77% |
D&A For EBITDA | 69.49 | 71.73 | 74.72 | 70.67 | 56.21 | 51.2 |
EBIT | -65.35 | 28.39 | -581.09 | 552.8 | 452.95 | 304.13 |
EBIT Margin | -4.11% | 1.33% | -38.55% | 32.13% | 26.44% | 24.62% |
Effective Tax Rate | - | - | - | 15.90% | 18.75% | 16.43% |
Revenue as Reported | 1,590 | 2,136 | 1,507 | 1,720 | 1,713 | 1,235 |
Advertising Expenses | - | 3.51 | 13.79 | 1.07 | 1.05 | 1.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.